Novel anti-calcification treatment of biological tissues by grafting of sulphonated poly(ethylene oxide)

Biomaterials

Volumn 18, Issue 1, 1997, Pages 47-51

  Park, Ki Dong ^a   Lee, Won Kyu ^a   Yun, Ju Young ^a   Han, Dong Keun ^a   Kim, Soo Hyun ^a   Kim, Young Ha ^a   Kim, Hyoung Mook ^b   Kim, Kwang Taek ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University   (South Korea)

Author keywords

Anti calcification; Sulphonated PEO; Tissue modification; Tissue valve

Indexed keywords

BIOCOMPATIBILITY; CALCIFICATION (BIOCHEMISTRY); CALCIUM; DEPOSITION; GRAFTING (CHEMICAL); IMPLANTS (SURGICAL); PHYSIOLOGICAL MODELS; POLYETHYLENE OXIDES; TISSUE;

BIOLOGICAL PORCINE TISSUES; GLUTARALDEHYDE FIXATION; NOVEL ANTICALCIFICATION TREATMENT; SULPHONATED POLYETHYLENE OXIDES;

HEART VALVE PROSTHESES;

GLUTARALDEHYDE; MACROGOL;

ANIMAL TISSUE; AORTA VALVE; ARTERY BYPASS; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CONTROLLED STUDY; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; AORTIC VALVE; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; DOGS; HEART VALVE PROSTHESIS; MALE; POLYETHYLENE GLYCOLS; PROSTHESES AND IMPLANTS; RATS; SULFONIC ACIDS; SWINE;

EID: 0031014822     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(96)00096-8     Document Type: Article

References (27)

1. Schoen FJ. Cardiac valve prostheses: review of clinical status and contemporary biomaterials issues. J Biomed Mater Res Appl Biomater 1987; 21: 91-117.
2. Levy RJ, Schoen FJ, Golomb G. Bioprosthetic heart valve calcification: clinical features, pathology, and prospects for prevention. CRC Crit Rev Biocompat 1986; 2(2): 147-187.
3. Schoen FJ, Harasaki H, Kim KM, Anderson HC, Levy RJ. Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 1988; 22: 11-36.
4. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1993; 113: 143-155.
5. Ferrans VJ, Boyce SW, Billingham ME, Jones M. Ishihara T, Robert WC. Calcine deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol 1980; 46: 721-734.
6. Thubrikar MJ, Deck DJ, Aouad J. Role of mechanical stress in calcification of aortic bioprosthetic valve. J Thorac Cardiovasc Surg 1986; 86: 115-125.
7. Levy RJ, Gundberg C, Scheinman R. The identification of the vitamin K dependent bone protein, osteocalcin, as one of the gamma-carboxyglutamic acid containing proteins present in calcified atheosclerotic plaque. Atherosclerosis 1983; 46: 49-56.
8. Levy RJ, Schoen F, Anderson HC et al. Cardiovascular implant calcification: a survey and updates. Biomaterials 1991; 12: 707-714.
9. Johnston TP, Bove EL, Bolling SF et al. Controlled release of 1-hydroxyethylidene diphosphonate: in vitro assessment and effects on bioprosthetic calcification in sheep tricuspid valve replacement. Int J Pharmaceut 1989; 52: 139-148.
10. 3+ and aminodiphosphonate preincubations. Am J Pathol 1992; 141: 487-496.
11. Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res 1993; 27: 1477-1484.
12. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde pretreated porcine bioprosthetic heart valves. Circulation 1994; 90: 323-329.
13. Nimni MN, Cheung D, Strates B et al. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1987; 21: 741-771.
14. Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials 1994; 15: 465-469.
15. Pereira CA, Lee JM, Haberer SA. Effect of alternative crosslinking methods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res 1990; 24: 345-361.
16. Harasaki H, Moritz A, Uchida N et al. LVAD mineralization of gamma-carboxy glutamic acid containing proteins in normal and pathologically manetalized tissue. Trans Am Soc Artif Intern Organs 1981; 27: 683.
17. Han DK, Jeong SY, Kim YH et al. Negative cilia concept for thromboresistance: synergistic effect of PEO and sulfonate groups grafted onto polyurethanes. J Biomed Mater Res 1993; 27: 1063-1073.
18. 3. J Biomed Mater Res 1993; 27: 1063-1073.
19. 3. ASAIO J 1993; 39: M537-M541.
20. Han DK, Lee NY, Park KD, Kim YH, Cho HI, Min BG. Heparin-like anti-coagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane. Biomaterials 1995; 16: 467-471.
21. Park KD, Yun JY, Han DK, Kim YH, Kim HM, Kim KT. Chemical modification of implantable biological tissue for anti-calcification. ASAIO J 1994; 40: M377-M382.
22. Blitterswijk CA, Brink J, Leenders H, Hesseling SC, Bakker D. Polyactive: a bone-bonding polymer effect of PEO/PBT proportion. Trans Soc Biomater 1991; 14: 11.
23. Frautschi JF, Phillips RE, Lupkowski M. Predictive calcification of poly(ether urethanes) with computer modeling. Trans Soc Biomater 1995; 18: 160.
24. Golomb G, Ezra V. Prevention of bioprosthetic heart valve tissue calcification by charge modification. J Biomed Mater Res 1991; 25: 85-89.
25. Nancollas GH. The mechanism of biological mineralization. J Crystal Growth 1977; 42: 185-193.
26. Coleman D. Mineralization of blood pump bladder. Trans Am Soc Artif Intern Organs 1981; 27: 708-713.
27. Han DK, Park KD, Ryu GH, Kim UY, Min BG, Kim YH. Plasma protein adsorption to sulfonated PEO-grafted PU surface. J Biomed Mater Res 1996; 30: 23-30.